Reprocessing Cost Analysis of Specimens Rejected in Laboratory: Results from the Perspective of the Costs to the Hospital

Basit Öğe Kaydı
dc.authoridKurutkan, Mehmet Nurullah/0000-0002-3740-4231
dc.contributor.authorBozdemir, Enver
dc.contributor.authorKurutkan, Mehmet Nurullah
dc.contributor.authorTerzi, Melek
dc.date.accessioned2023-07-26T11:57:32Z
dc.date.available2023-07-26T11:57:32Z
dc.date.issued2022
dc.departmentDÜ, İşletme Fakültesi, Sağlık Yönetimi Bölümüen_US
dc.description.abstractObjective: The objective of the study is to analyze the additional costs of reprocessing the specimens rejected in the laboratory to the hospital. Methods: The data is acquired from the Duzce University Medical Application and Research Hospital (DUMARH) laboratories. 5-year (20152019) data was retrospectively reviewed and subjected to document analysis. Results: The rate of the total rejected specimens has increased throughout the years. (2015, 0.88% - 2019, 2.12%). The most prominent rejection reasons are hemolysis specimen (32.9%), insufficient specimen (17.25%), clotted specimen (15.4%) and inaccurate examination request (10.64%). While the reprocessing cost of specimens was 12.085 dollars in 2015, it increased to 51.132 dollars in 2019. It is seen that the rejection rate has increased as the specimen number increased and the reprocessing costs have increased since the inflation in Turkey increased and the purchasing power of the hospital has decreased throughout the years. Conclusion: In order to decrease and prevent the rejected specimen, there is a need for phlebotomy training, especially for nursing and other healthcare professionals, and strict quality control and standard operating procedures for the pre-analytical phase. These are the critical approaches that will improve the service quality of laboratories and patient safety.en_US
dc.identifier.doi10.33808/clinexphealthsci.804238
dc.identifier.endpage74en_US
dc.identifier.issn2459-1459
dc.identifier.issue1en_US
dc.identifier.startpage67en_US
dc.identifier.trdizinid1127939en_US
dc.identifier.urihttps://doi.org/10.33808/clinexphealthsci.804238
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1127939
dc.identifier.urihttps://hdl.handle.net/20.500.12684/13220
dc.identifier.volume12en_US
dc.identifier.wosWOS:000782846300010en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorBozdemir, Enver
dc.institutionauthorKurutkan, Mehmet Nurullah
dc.institutionauthorTerzi, Melek
dc.language.isoenen_US
dc.publisherMarmara Univ, Inst Health Sciencesen_US
dc.relation.ispartofClinical and Experimental Health Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.subjectLaboratory; Rejected Specimen; Reprocessing; Cost Analysisen_US
dc.subjectPreanalytical Errors; Impact; Quality; Ratesen_US
dc.titleReprocessing Cost Analysis of Specimens Rejected in Laboratory: Results from the Perspective of the Costs to the Hospitalen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
13220.pdf
Boyut:
381.09 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu